Biocore’s staff will be directly supporting both surgical and cardiac catheter lab procedures, as well as assisting cardiac surgeons and electrophysiologists with Cardima’s solutions for patient care.
This relationship is expected to strengthen Cardima’s Surgical Program commercial launch in the US by leveraging the existing relationships Biocore has with physicians and hospitals in the eastern US.
Robert Cheney, Cardima’s CEO, said: “Biocore has over 20 years of experience in this field and complementary relationships with our key surgical customers. With Biocore’s experience in the ablation and diagnostic markets, they will strengthen Cardima’s market presence in the eastern US. Their track record for providing customer support and sales growth makes Biocore an ideal partner to represent and support Cardima’s EP and surgical products.”